NCTN Assessment on Current Applications of Radiomics in Oncology. Int J Radiat Oncol Biol Phys 2019 Jun 01;104(2):302-315
Date
02/04/2019Pubmed ID
30711529Pubmed Central ID
PMC6499656DOI
10.1016/j.ijrobp.2019.01.087Scopus ID
2-s2.0-85064671471 (requires institutional sign-in at Scopus site) 57 CitationsAbstract
Radiomics is a fast-growing research area based on converting standard-of-care imaging into quantitative minable data and building subsequent predictive models to personalize treatment. Radiomics has been proposed as a study objective in clinical trial concepts and a potential biomarker for stratifying patients across interventional treatment arms. In recognizing the growing importance of radiomics in oncology, a group of medical physicists and clinicians from NRG Oncology reviewed the current status of the field and identified critical issues, providing a general assessment and early recommendations for incorporation in oncology studies.
Author List
Nie K, Al-Hallaq H, Li XA, Benedict SH, Sohn JW, Moran JM, Fan Y, Huang M, Knopp MV, Michalski JM, Monroe J, Obcemea C, Tsien CI, Solberg T, Wu J, Xia P, Xiao Y, El Naqa IMESH terms used to index this publication - Major topics in bold
Decision Support Systems, ClinicalGenomics
Humans
Image Processing, Computer-Assisted
Logistic Models
Machine Learning
Magnetic Resonance Imaging
Neoplasms
Phantoms, Imaging
Pharmacokinetics
Phenotype
Positron-Emission Tomography
Radiation Oncology
Reproducibility of Results
Tomography, X-Ray Computed
Treatment Outcome
